Martin Shkreli running business, “at work on a big second act.”


Martin Shkreli running business, “at work on a big second act.”.

While Martin “Pharma Bro” Shkreli has been imprisoned since September 2017, convicted of defrauding investors, among other crimes, it appears he’s still running his company.

According to a report from The Wall Street Journal, Shkreli is “at work on a big second act.”

READ  ‘It Will Be Hard to Vote’ for Next Pope (Report)

Shkreli does not have the same power he once did as founder and CEO of Turing Pharmaceuticals AG. For one, the company has been renamed Phoenixus AG, to distance itself from Shkreli.

Nevertheless, the WSJ suggests that Shkreli “still helps call the shots.” Using a contraband smartphone from his prison cell, Shkreli’s involvement even has gone so far as reportedly firing the CEO Kevin Mulleady, whom Shkreli had appointed.

READ  At Least 10 Dead in Massive Northern California Wildfire –

Shkreli reportedly spends much of his free time researching diseases and pharmaceuticals, plotting to acquire more drugs and invest in research and development. If Shkreli’s calculations hold up, Phoenixus could be worth $3.7 billion when he becomes a free man in 2023.

READ  Kevin Spacey Accused In New Lawsuit of Sex Offenses Against Teenagers –

Shkreli, still a company shareholder, is being investigated by the FBI for continuing to be involved in the company. While the WSJ was unable to interview Shkreli in prison, the report notes the prison inmate handbook prohibits “conducting a business in any way.”


Please enter your comment!
Please enter your name here